Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2511545 | Antiviral Research | 2006 | 9 Pages |
Abstract
The treatment of severe adenovirus keratoconjunctivitis and life-threatening adenovirus infections in immunocompromised patients is still unsatisfactory. We here review the mode of action and antiviral data for cidofovir and ribavirin, obtained in cell culture, animal models or patients. Several nucleoside or nucleotide analogues have been described that target the adenovirus polymerase, whereas other antiviral targets have been poorly investigated. Furthermore, optimal therapeutic response may be achieved by combining antiviral therapy with immunotherapeutic approaches, as currently being explored.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
L. Lenaerts, L. Naesens,